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Sickle cell nephropathy (SCN) is a chronic manifestation of sickle
cell disease (SCD). We previously found that reactive oxygen species
(ROS) were elevated in the glomeruli from SCD mice. Importantly,
treatment with ABT-627, a selective ET-A receptor antagonist, re-
duced glomerular ROS production in SCD mice to levels observed in
controls. Because SCN is thought to progress secondary to repeated
occlusions in the microvasculature, we hypothesized that hypoxia
stimulates the production of glomerular ET-1, causing deleterious
effects through over-production of ROS. To directly test if ET-1 is
increased in response to hypoxia in unaffected mice, we exposed
vascular endothelial ET-1 knockout (VEET) mice and ﬂoxed controls
to normoxia or 3 h of hypoxia (8% O2). In response to hypoxia, ﬂoxed
mice had signiﬁcant increases in glomerular ET-1 mRNA while there
was no response to hypoxia in the VEETmice, indicating that hypoxia
stimulates endothelial-derived glomerular ET-1 (ﬂoxed hypoxia:
2.1 ± 0.2, ﬂoxed normoxia: 1.1 ± 0.2, VEET hypoxia: 0.7 ± 0.1, VEET
normoxia: 0.8 ± 0.3 fold change, p b 0.01, n = 6/group). To deter-
mine the inﬂuence of chronically elevated ET-1 on glomerular ROS
production, C57BL/6J mice were treated with saline or ET-1 (2 weeks
@2 pg/kg/day) via a miniosmotic pump. Mice treated with ET-1
demonstrated signiﬁcant increases in stimulated ROS production
compared to saline controls (5452 ± 655 vs. 2177 ± 359 luminescence/
protein∗min, p b 0.01, n = 5–6). These data reveal that hypoxia leads
to upregulation of endothelial-derived glomerular ET-1 and that chronic
elevations in ET-1, similar to what is seen in SCD, increase ROS pro-
duction in the glomeruli. Taken together, these data identify a novel
mechanism by which hypoxia stimulates the upregulation of ET-1 in
glomerular endothelial cells and promotes glomerular ROS production.
doi:10.1016/j.lfs.2013.12.079
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Hypertension plays a critical role in the progression of chronic
kidney disease (CKD). Recent studies have shown that besides the
inappropriately activated renin–angiotensin system (RAS), enhanced
intrarenal activity of the endothelin (ET) system via activation of ET
receptor type A (ETA) contributes to the pathophysiology of hyper-
tension and progression of CKD. We therefore evaluated whether
addition of selective ETA receptor blockade to the standard RAS
blockade will exhibit additional beneﬁcial effects on the progression
of CKD. Ren-2 transgenic rats (TGR) underwent 5/6 renal ablation
(5/6 NX) serving as model of CKD. A combination of angiotensin-
converting enzyme inhibitor (trandolapril, 6 mg/l drinking water) and
angiotensin II receptor blocker (losartan, 100 mg/l drinking water)
was used. ETA receptor blocker (atrasentan, 5 mg·kg−1·day−1) was
employed with the combination of RAS blockade. The follow-up period
was 44 weeks after 5/6 NX. The following parameters were evaluated:
survival rate, systolic blood pressure (SBP), proteinuria and renal glo-
merular damage. Both therapeutical regimes improved survival rate,
however the efﬁciency of isolated RAS blockade considerably decreased
at 36 weeks after 5/6 NX (ﬁnal survival rate was 65%). The combined
RAS and ETA receptor blockade exhibited a ﬁnal survival rate of 91%,
which was signiﬁcantly better as compared with isolated RAS in-
hibition, even if there were no signiﬁcant differences in SBP among the
experimental groups. In addition, the RAS and ETA receptor blockade
further reduced proteinuria and renal glomerular damage. Our data
show that a combined RAS and ETA receptor blockade exhibited
additional beneﬁcial effects on the progression of CKD in 5/6 NX TGR as
compared with isolated RAS inhibition.
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Septic acute kidney injury (AKI) remains associated with high
mortality rate, partially, because of the poor understanding of its
(patho)physiology. Endothelin-1 (ET-1), which is produced and is
secreted from vascular endothelium, plays important roles on renal
hemodynamics via autocrine/paracrine and, possibly, hormonal mech-
anisms. Previous studies have demonstrated that either selective or
non-selective endothelin antagonists attenuate the hemodynamic
changes in experimental sepsis models. Thus, we investigated the role
of endothelial cell-derived ET-1 on the severity of lipopolysaccharide
(LPS)-induced AKI by using endothelial cell-speciﬁc ET-1 knock-out
mice (VEETKO). The renal microcirculation dynamics was observed by
intravital 2-photon laser microscopy. LPS (from Escherichia coli O55:B5,
5 mg/kg, i.p.) increased leukocyte attachment in the capillary walls,
whereas there was maintained plasma ﬂow in the peritubular capillar-
ies in VEETKO. The urine ﬂow rate was reduced to half in VEETKO
compared with that in normal (LPS-untreated) C57B6 mice, while the
blood urea nitrogen level was still at normal level in VEETKO (22.8 ±
0.2 mg/dL vs. 52.9 ± 12.7 mg/dL in C57B6) at 24 h after LPS injection.
Fluid resuscitation (1.5 mL of saline, s.c., at 6 and 14 h after LPS)
normalized the LPS-induced increase in leukocyte attachment and the
decrease in urine ﬂow rate in VEETKO, but the effects were partial in
C57B6 mice. These results suggest that VEETKO kidney is less sensitive
against endotoxemia than the kidney of C57B6mice, and that leukocyte
attachment and reduction of urine ﬂow in VEETKO may be due to the
decrease in blood pressure by endotoxemia in combination with the
lack of ET-1.
doi:10.1016/j.lfs.2013.12.081
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